IGF2BP1 and neoplasm: Two different public databases, the Tumour Immune Estimation Resource (TIMER; http://timer.cistrome.org/ [18], accessed on 30 August 2023) and the Gene Expression Profiling Interactive Analysis database (GEPIA; http://gepia.cancer-pku.cn/detail.php?gene=IGF2BP1###, accessed on 30 August 2023) [19], showed that IMP1 mRNA was strongly expressed in some solid cancers, including PDAC, matching with normal tissues (Figure 1A,B).